| Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the … HAP Pols, D Felsenberg, DA Hanley, J Štepán, M Munoz-Torres, ... Osteoporosis International 9, 461-468, 1999 | 811 | 1999 |
| Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2 … AJ Garber, AB King, S Del Prato, S Sreenan, MK Balci, M Muñoz-Torres, ... The Lancet 379 (9825), 1498-1507, 2012 | 455 | 2012 |
| Documento de consenso para la detección y manejo de la enfermedad renal crónica A Martínez-Castelao, JL Górriz, J Bover, J Segura-de la Morena, ... Endocrinología y nutrición 61 (9), e25-e43, 2014 | 383 | 2014 |
| Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis FJ Gallego-Rojo, JL Gonzalez-Calvin, M Muñoz-Torres, JL Mundi, ... Hepatology 28 (3), 695-699, 1998 | 329 | 1998 |
| Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus A García-Martín, P Rozas-Moreno, R Reyes-García, S Morales-Santana, ... The journal of clinical endocrinology & metabolism 97 (1), 234-241, 2012 | 328 | 2012 |
| Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women P Mezquita‐Raya, M Muñoz‐Torres, J De Dios Luna, V Luna, ... Journal of Bone and Mineral research 16 (8), 1408-1415, 2001 | 288 | 2001 |
| Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus M Munoz-Torres, E Jodar, F Escobar-Jimenez, PJ Lopez-Ibarra, JD Luna Calcified tissue international 58, 316-319, 1996 | 253 | 1996 |
| Consensus document for the detection and management of chronic kidney disease G de Redactores, A Martínez-Castelao, JL Górriz-Teruel, J Bover-Sanjuán, ... Nefrología (English Edition) 34 (2), 243-262, 2014 | 179 | 2014 |
| Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism JL GONZALEZ-CALVIN, A Garcia-Sanchez, V Bellot, M Munoz-Torres, ... Alcohol and Alcoholism 28 (5), 571-579, 1993 | 163 | 1993 |
| The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women P Mezquita-Raya, M de la Higuera, DF García, G Alonso, ... Osteoporosis international 16, 1368-1374, 2005 | 159 | 2005 |
| Nutrients and dietary patterns related to osteoporosis A Muñoz-Garach, B García-Fontana, M Muñoz-Torres Nutrients 12 (7), 1986, 2020 | 158 | 2020 |
| Effect of tobacco consumption on bone mineral density in healthy young males N Ortego-Centeno, M Munoz-Torres, E Jodar, J Hernandez-Quero, ... Calcified tissue international 60, 496-500, 1997 | 152 | 1997 |
| Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels S Morales-Santana, B García-Fontana, A GARCia-MARTin, ... Diabetes care 36 (6), 1667-1674, 2013 | 145 | 2013 |
| Calcitonin therapy in osteoporosis M Muñoz-Torres, G Alonso, P Mezquita Raya Treatments in endocrinology 3, 117-132, 2004 | 140 | 2004 |
| Quantitative ultrasound calcaneus measurements: normative data and precision in the Spanish population M Sosa, P Saavedra, M Munoz-Torres, J Alegre, C Gómez, ... Osteoporosis international 13, 487-492, 2002 | 126 | 2002 |
| Serum levels of bone resorption markers are decreased in patients with type 2 diabetes R Reyes-García, P Rozas-Moreno, G López-Gallardo, A García-Martín, ... Acta diabetologica 50, 47-52, 2013 | 95 | 2013 |
| Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause E Jódar, M Muñoz‐Torres, F Escobar‐Jiménez, M Quesada‐Charneco, ... Clinical Endocrinology 47 (3), 279-285, 1997 | 95 | 1997 |
| Risk factors for prediction of inadequate response to antiresorptives A Díez‐Pérez, JM Olmos, X Nogués, M Sosa, M Díaz‐Curiel, ... Journal of Bone and Mineral Research 27 (4), 817-824, 2012 | 94 | 2012 |
| Effect of raloxifene after recombinant teriparatide [hPTH (1–34)] treatment in postmenopausal women with osteoporosis S Adami, J San Martin, M Muñoz-Torres, MJ Econs, L Xie, GP Dalsky, ... Osteoporosis international 19, 87-94, 2008 | 92 | 2008 |
| Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women A García-Martín, R Reyes-García, M Muñoz-Torres Endocrine 42, 764-766, 2012 | 85 | 2012 |
